AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - NYSE:AMN - US0017441017 - Common Stock
20.51 USD
+0.65 (+3.27%)
20.51 USD
0 (0%)
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of AMN while its profitability can be described as average. AMN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
In the past year AMN had a positive cash flow from operations.
AMN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years AMN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AMN (-13.46%) is worse than 79.21% of its industry peers.
AMN has a Return On Equity of -49.02%. This is in the lower half of the industry: AMN underperforms 73.27% of its industry peers.
The Return On Invested Capital of AMN (2.66%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for AMN is above the industry average of 9.33%.
The last Return On Invested Capital (2.66%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.46% | ||
| ROE | -49.02% | ||
| ROIC | 2.66% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN's Operating Margin of 2.12% is in line compared to the rest of the industry. AMN outperforms 50.49% of its industry peers.
AMN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 29.84%, AMN is in line with its industry, outperforming 56.44% of the companies in the same industry.
In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.12% | ||
| PM (TTM) | N/A | ||
| GM | 29.84% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMN is creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
Compared to 5 years ago, AMN has less shares outstanding
The debt/assets ratio for AMN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.38 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score (2.38) which is in line with its industry peers.
The Debt to FCF ratio of AMN is 3.59, which is a good value as it means it would take AMN, 3.59 years of fcf income to pay off all of its debts.
AMN's Debt to FCF ratio of 3.59 is fine compared to the rest of the industry. AMN outperforms 74.26% of its industry peers.
AMN has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AMN (1.51) is worse than 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 3.59 | ||
| Altman-Z | 2.38 |
ROIC/WACC0.35
WACC7.53%
2.3 Liquidity
AMN has a Current Ratio of 1.00. This is a bad value and indicates that AMN is not financially healthy enough and could expect problems in meeting its short term obligations.
AMN has a worse Current ratio (1.00) than 72.28% of its industry peers.
A Quick Ratio of 1.00 indicates that AMN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, AMN is doing worse than 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.73%.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
Looking at the last year, AMN shows a very negative growth in Revenue. The Revenue has decreased by -14.33% in the last year.
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
3.2 Future
The Earnings Per Share is expected to grow by 22.82% on average over the next years. This is a very strong growth
AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.40% yearly.
EPS Next Y-65.14%
EPS Next 2Y-42.68%
EPS Next 3Y-22.59%
EPS Next 5Y22.82%
Revenue Next Year-12.08%
Revenue Next 2Y-7.19%
Revenue Next 3Y-3.17%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.72, the valuation of AMN can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 92.08% of the companies listed in the same industry.
AMN is valuated cheaply when we compare the Price/Earnings ratio to 27.77, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.86, which indicates a rather expensive current valuation of AMN.
65.35% of the companies in the same industry are more expensive than AMN, based on the Price/Forward Earnings ratio.
AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.72 | ||
| Fwd PE | 18.86 |
4.2 Price Multiples
82.18% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 99.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.08 | ||
| EV/EBITDA | 7.45 |
4.3 Compensation for Growth
A cheap valuation may be justified as AMN's earnings are expected to decrease with -22.59% in the coming years.
PEG (NY)N/A
PEG (5Y)12.08
EPS Next 2Y-42.68%
EPS Next 3Y-22.59%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
20.51
+0.65 (+3.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.31%
Inst Owner Change0.1%
Ins Owners0.42%
Ins Owner Change0.71%
Market Cap785.94M
Analysts69.23
Price Target20.4 (-0.54%)
Short Float %8.71%
Short Ratio3.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.83%
Min EPS beat(2)53.64%
Max EPS beat(2)116.02%
EPS beat(4)4
Avg EPS beat(4)56.81%
Min EPS beat(4)5.34%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)34.9%
EPS beat(12)12
Avg EPS beat(12)26.31%
EPS beat(16)16
Avg EPS beat(16)23.47%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.88%
Revenue beat(4)3
Avg Revenue beat(4)1.99%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.84%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)11
Avg Revenue beat(16)1.97%
PT rev (1m)0%
PT rev (3m)-24.63%
EPS NQ rev (1m)-3.03%
EPS NQ rev (3m)-13.98%
EPS NY rev (1m)-1.93%
EPS NY rev (3m)1.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.33%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-2.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.72 | ||
| Fwd PE | 18.86 | ||
| P/S | 0.28 | ||
| P/FCF | 3.08 | ||
| P/OCF | 2.53 | ||
| P/B | 1.29 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.45 |
EPS(TTM)2.11
EY10.29%
EPS(NY)1.09
Fwd EY5.3%
FCF(TTM)6.67
FCFY32.51%
OCF(TTM)8.11
OCFY39.54%
SpS72.28
BVpS15.86
TBVpS-12.28
PEG (NY)N/A
PEG (5Y)12.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.46% | ||
| ROE | -49.02% | ||
| ROCE | 3.58% | ||
| ROIC | 2.66% | ||
| ROICexc | 2.73% | ||
| ROICexgc | 8.39% | ||
| OM | 2.12% | ||
| PM (TTM) | N/A | ||
| GM | 29.84% | ||
| FCFM | 9.22% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 3.59 | ||
| Debt/EBITDA | 4.11 | ||
| Cap/Depr | 33.64% | ||
| Cap/Sales | 1.99% | ||
| Interest Coverage | 1.13 | ||
| Cash Conversion | 139.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.38 |
F-Score4
WACC7.53%
ROIC/WACC0.35
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
EPS Next Y-65.14%
EPS Next 2Y-42.68%
EPS Next 3Y-22.59%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
Revenue Next Year-12.08%
Revenue Next 2Y-7.19%
Revenue Next 3Y-3.17%
Revenue Next 5Y4.4%
EBIT growth 1Y-70.44%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year92.53%
EBIT Next 3Y25.77%
EBIT Next 5YN/A
FCF growth 1Y-32.27%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-33.9%
OCF growth 3Y1.61%
OCF growth 5Y7.34%